JOIN THE BATTLE. GIVE TO BEAT RARE CANCERS.
TeamteenCT will be the first teen ride ever in Connecticut! Cycle for Survival raises funds and awareness for rare cancers. ALL pediatric cancers are rare cancers!!! Below are examples of how last year's Cycle for Survival fundraising helped pediatric cancer research!
Advancing a Vital Discovery on the Cause of Childhood Cancer
1. Pediatric Cancer
The Battle: Understanding how aggressive tumors develop in children.
Cycle for Survival funded... The next phase of an important study. Researchers at MSK discovered that a gene called PGBD5 can sometimes turn healthy cells cancerous during childhood.
And now... Dr. Alex Kentsis’ team is exploring how the gene works. Their goal: to find a treatment that will boost survival for children facing cancer.
2. Pediatric Cancer
To develop the next generation of therapies for our youngest patients, Dr. Andrew Kung, Chair of MSK’s Department of Pediatrics, is focused on whole genome sequencing—a process that reveals a child’s full DNA code. This in-depth analysis will allow researchers to identify vulnerabilities to target for safely and effectively destroying cancer.
3. Pediatric Brain Cancer
Dr. Alexandra Joyner’s lab is studying the cellular changes and signaling networks driving medulloblastoma, the most common malignant brain tumor in children. By synchronizing lab-based models with clinical efforts, they aim to identify new targets for the development of therapies designed to improve outcomes and quality of life.
I'm raising money for rare cancer research with Cycle for Survival, the movement to beat rare cancers. Join me in this fight by making a donation. It's something we can all do to make a difference for those battling cancer.
Here's how your gift will make an impact:
50% of People with Cancer Have a Rare Cancer
When combined, rare cancers make up approximately half of patients fighting cancer. Rare cancers—such as leukemia, lymphoma, thyroid, ovarian, pancreatic, and pediatric cancers—are diseases we all know. These patients often face little to no treatment options because rare cancer research is underfunded.
100% Goes to Lifesaving Research Led by MSK
Every dollar you give will advance innovative research and clinical trials led by Memorial Sloan Kettering. This work has the power to revolutionize how cancer is diagnosed and treated worldwide. There's no time to waste: with your help, new discoveries will be made each year.
Thank you for your support!